Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Arterial Resistive Index Versus Novel Serum and Urinary Biomarkers for Early Prediction of Sepsis Associated-acute Kidney Injury in Critically Ill Patients

NCT03799159 is registered in ClinicalTrials.gov with Islam Elsayed Mohamed Ahmed as lead sponsor.

NCT NCT03799159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03799159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Arterial Resistive Index Versus Novel Serum and Urinary Biomarkers for Early Prediction of Sepsis Associated-acute Kidney Injury in Critically Ill Patients
Lead sponsor
Islam Elsayed Mohamed Ahmed
Phase
Observational
Overall status
Completed
Start date
May 15, 2019
Completion date
February 28, 2021
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, sepsis, septic shock